Noticias de PFE_US
Noticias del mercado
Últimas noticias sobre PFE_US — 665 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Pfizer stock is at EUR 24.51 in pre-market trading at Lang & Schwarz, up 0.41 percent versus the EUR
Pfizer Inc. (NYSE:PFE) was trading at around $27 on October 5, down 1.35% on the day and up 5.18% over twelve months. The shares yield 6.19%. The company paid out 226.32% of its earnings to do it. Those two facts have to be reconciled before anything else about this stock matters. READ ALSO: What is […]
Pfizer stock traded at USD 27.50 on October 6, 2026, up 0.31 percent intraday. Q2 revenue reached US
Pfizer raised its 2026 revenue guidance midpoint by USD 500 million after second-quarter growth. Pfi
NEW YORK, October 06, 2026--Pfizer Inc. (NYSE: PFE) today announced that its board of directors declared a $0.43 fourth-quarter 2026 dividend on the company’s common stock, payable December 7, 2026, to holders of the Common Stock of record at the close of business on November 6, 2026.
Florida Attorney General James Uthmeier filed a lawsuit against Pfizer, accusing the biopharmaceutical company of deceiving Florida consumers about the safety risks of its COVID-19 vaccine and whether the vaccine could stop the spread of the virus.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Key TakeawaysVaxcyte’s VAX-31 matched Pfizer’s Prevnar 20 on all 20 shared serotypes and Merck’s Capvaxive on 17 of 19 in a 4,047-person Phase 3 trial. Prevnar brought in $6.
Vaxcyte said its experimental pneumococcal vaccine hit the primary endpoints in a Phase 3 clinical trial, setting up the biotech to compete with Pfizer and Merck.
Moderna stock has surged nearly 600% this year on a cancer vaccine trial result that almost no one outside the trial has actually seen in full. What happens when Madrid finally puts the complete data in front of the market?
Página 18 de 34